LON:MDC Mediclinic International (MDC) Share Forecast, Price & News GBX 501 0.00 (0.00%) (As of 05/26/2023) Add Compare Share Share Today's Range 501▼ 50150-Day Range 494.17▼ 50152-Week Range 366.80▼ 514VolumeN/AAverage Volume2.68 million shsMarket Capitalization£3.69 billionP/E Ratio2,178.26Dividend Yield0.60%Price TargetGBX 484 ProfileProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesOptions ChainProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesOptions Chain Mediclinic International MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside3.4% DownsideGBX 484 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.67 out of 5 stars 1.0 Analyst's Opinion Consensus RatingMediclinic International has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 484, Mediclinic International has a forecasted downside of 3.4% from its current price of GBX 501.Amount of Analyst CoverageMediclinic International has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for MDC. Previous Next 0.0 Dividend Strength Dividend YieldMediclinic International has a dividend yield of 0.60%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthMediclinic International does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Mediclinic International is 1,304.35%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MDC. Previous Next 0.7 News and Social Media Coverage News SentimentMediclinic International has a news sentiment score of -0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.Search InterestOnly 7 people have searched for MDC on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mediclinic International insiders have not sold or bought any company stock.Percentage Held by Insiders48.87% of the stock of Mediclinic International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 39.20% of the stock of Mediclinic International is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Mediclinic International is 2,178.26, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 139.59.Price to Earnings Ratio vs. SectorThe P/E ratio of Mediclinic International is 2,178.26, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 144.57.Price to Book Value per Share RatioMediclinic International has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Mediclinic International (LON:MDC) StockMediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.Read More Receive MDC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter. Email Address MDC Stock News HeadlinesMay 12, 2023 | americanbankingnews.comMediclinic International (LON:MDC) Stock Passes Below 50 Day Moving Average of $498.24April 30, 2023 | americanbankingnews.comMediclinic International (LON:MDC) Stock Price Crosses Below Fifty Day Moving Average of $498.19June 1, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.March 27, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 24-March-23 Decrease in Trading Position DisclosureMarch 16, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 15-March-23 Dealing DisclosureMarch 13, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 10-March-23 Increase in Traded Position DisclosureFebruary 24, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 23-February-23 Dealing DisclosureFebruary 21, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 20-February-23 Increase in Traded PositionJune 1, 2023 | Vector Vest (Ad)Master Market Movements: Free Stock Analysis Report with Predictive Buy/Sell/Hold Insights!Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation. February 20, 2023 | finance.yahoo.comForm 8.3 - Mediclinic International plc AmendmentFebruary 2, 2023 | msn.comMediclinic Southern Africa expands into precision medicineJanuary 31, 2023 | msn.comEarnings Preview For M.D.C. HoldingsJanuary 27, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 26-January-23 Decrease in Traded PositionJanuary 19, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 18-January-23 Dealing DisclosureJanuary 10, 2023 | finance.yahoo.comForm 8.3 - MDC LN Equity 09-January-23 Decrease in Traded Position DisclosureDecember 19, 2022 | finance.yahoo.comForm 8.3 - MDC LN Equity 16-December-22 Decrease DisclosureNovember 28, 2022 | finance.yahoo.comForm 8.3 - MDC LN Equity 25-November-22 Dealing DisclosureNovember 17, 2022 | msn.comMedi Assist acquires majority stake in UK-based MayfairNovember 16, 2022 | nasdaq.comMediclinic Intl H1 Profit Rises, Adj. EBITDA DownSeptember 26, 2022 | msn.comLooking like their patients — UM, MDC work to get more people of color into medical schoolSeptember 12, 2022 | finance.yahoo.comForm 8.3 - Mediclinic International plc - AmendmentSeptember 5, 2022 | uk.finance.yahoo.comMediclinic International plc (MDC.L)August 4, 2022 | finance.yahoo.comConsortium to buy S.Africa hospitals firm Mediclinic for $4.49 billionAugust 4, 2022 | finance.yahoo.comLondon-listed hospital group Mediclinic accepts £3.7bn offerJuly 20, 2022 | finance.yahoo.comHow Many Mediclinic International plc (LON:MDC) Shares Do Institutions Own?July 14, 2022 | finance.yahoo.comForm 8.3 - Mediclinic International plcJune 7, 2022 | uk.finance.yahoo.comAs Mediclinic International (LON:MDC) hits a new 52-week high, what should shareholders do?See More Headlines MDC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeLON Industry Medical Care Sub-IndustryN/A SectorMedical Current SymbolLON:MDC Previous SymbolLON:ANH CUSIPN/A CIKN/A Webwww.mediclinic.com Phone+44-20-79549600FaxN/AEmployees30,470Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 484 High Stock Price ForecastGBX 504 Low Stock Price ForecastGBX 464 Forecasted Upside/Downside-3.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.23 Trailing P/E Ratio2,178.26 Forward P/E Ratio0.16 P/E GrowthN/ANet Income£169 million Net Margins4.99% Pretax MarginN/A Return on Equity5.50% Return on Assets2.30% Debt Debt-to-Equity Ratio78.38 Current Ratio1.49 Quick Ratio1.38 Sales & Book Value Annual Sales£3.38 billion Price / Sales1.09 Cash FlowGBX 62.27 per share Price / Cash Flow8.05 Book ValueGBX 481 per share Price / Book1.04Miscellaneous Outstanding Shares737,240,000Free FloatN/AMarket Cap£3.69 billion OptionableOptionable Beta0.42 Key ExecutivesDr. Carel Aron van der Merwe D.A. (SA) (Age 60)F.C.A. (SA), M.B.Ch.B., Group CEO & Exec. Director Comp: $1.37MMr. Petrus Jurgens Myburgh (Age 48)Group CFO & Exec. Director Comp: $918kMr. Koert H. S. Pretorius B.Compt (Age 60)MBL, Group Chief Operating Officer Dr. Dirk C. Le Roux (Age 63)Group Chief Information Officer Mr. James ArnoldHead of Investor RelationsMr. Gert C. Hattingh B.Acc. (Hons) (Age 58)CA(SA), Group Chief Governance Officer Mr. Biren ValodiaChief Marketing Officer of Medi-Clinic Southern AfricaMs. Clara FindlayChief Legal Officer of Medicalinic Southern AfricaMr. Wimpie AucampChief Operating Officer of Medi-Clinic for Southern AfricaMr. David J. Hadley (Age 49)Chief Exec. Officer of Medicalinic Middle East More ExecutivesKey CompetitorsDechra PharmaceuticalsLON:DPHHikma PharmaceuticalsLON:HIKBTGLON:BTGConvaTec GroupLON:CTECAbcamLON:ABCView All Competitors MDC Stock - Frequently Asked Questions Should I buy or sell Mediclinic International stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares. View MDC analyst ratings or view top-rated stocks. What is Mediclinic International's stock price forecast for 2023? 2 analysts have issued 12 month target prices for Mediclinic International's stock. Their MDC share price forecasts range from GBX 464 to GBX 504. On average, they expect the company's share price to reach GBX 484 in the next twelve months. This suggests that the stock has a possible downside of 3.4%. View analysts price targets for MDC or view top-rated stocks among Wall Street analysts. How have MDC shares performed in 2023? Mediclinic International's stock was trading at GBX 498 at the beginning of the year. Since then, MDC shares have increased by 0.6% and is now trading at GBX 501. View the best growth stocks for 2023 here. Is Mediclinic International a good dividend stock? Mediclinic International (LON:MDC) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 0.60%. The dividend payout ratio is 1,304.35%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for MDC. What other stocks do shareholders of Mediclinic International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO). What is Mediclinic International's stock symbol? Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC." How do I buy shares of Mediclinic International? Shares of MDC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Mediclinic International's stock price today? One share of MDC stock can currently be purchased for approximately GBX 501. How much money does Mediclinic International make? Mediclinic International (LON:MDC) has a market capitalization of £3.69 billion and generates £3.38 billion in revenue each year. The company earns £169 million in net income (profit) each year or GBX 0.23 on an earnings per share basis. How many employees does Mediclinic International have? The company employs 30,470 workers across the globe. How can I contact Mediclinic International? Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The official website for the company is www.mediclinic.com. The company can be reached via phone at +44-20-79549600. This page (LON:MDC) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mediclinic International plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.